Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Jul;17(5):410-9.
doi: 10.1177/1087054712446173. Epub 2012 May 22.

EEG neurofeedback for ADHD: double-blind sham-controlled randomized pilot feasibility trial

Affiliations
Randomized Controlled Trial

EEG neurofeedback for ADHD: double-blind sham-controlled randomized pilot feasibility trial

L Eugene Arnold et al. J Atten Disord. 2013 Jul.

Abstract

Objective: Preparing for a definitive randomized clinical trial (RCT) of neurofeedback (NF) for ADHD, this pilot trial explored feasibility of a double-blind, sham-controlled design and adherence/palatability/relative effect of two versus three treatments/week.

Method: Unmedicated 6- to 12-year-olds with Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV) ADHD were randomized to active NF versus sham-NF and to 2X versus 3X/week treatment frequency. Frequency switch was allowed after Treatment 24.

Results: In two school years, 39 participants were recruited and 34 (87%) completed all 40 treatments. Child/parent guesses about assigned treatment were no better than chance. At Treatment 24, 38% chose 2X/week and 62% chose 3X/week. Both active NF and sham yielded large pre-post improvement on parent ratings but NF no more than sham.

Conclusion: Blinding appears to work, and sham does not prevent recruitment/retention. Treatment frequency of 3X/week seems preferred over 2X/week and was as effective. A large double-blind RCT is feasible and necessary to test specific NF effectiveness.

Keywords: ADHD; adolescent; neurofeedback.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CONSORT Diagram
Fig. 2
Fig. 2
Relative efficacy of 2 vs. 3X/week active NF treatments by teacher ratings (upper panel) and parent ratings (lower panel) on the 18 DSM-IV ADHD symptoms on the SNAP (0-3 metric, lower score better). N=13 for each assigned frequency of active NF.
Fig. 3
Fig. 3
Asymptote of Active NF Treatment Effect by Treatment 24 on the 18 DSM-IV ADHD Symptoms Rated by Parents on SNAP (0-3 scale, lower score is better, ratings every 3 treatments)
Fig. 4
Fig. 4
Outcome Trajectories through 40 Treatments & 2-month follow-up for Parent-rated Inattention (top left panel), Hyperactivity-Impulsivity (top right panel), & all 18 ADHD symptoms (lower left panel) and Teacher-Rated all 18 ADHD Symptoms (lower right panel) on SNAP (0-3 scale, lower score is better). Treatment #50 = follow-up 2 months after end of treatment

Similar articles

Cited by

References

    1. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2 ed Lawrence Earlbaum Associates; Hillsdale, NJ: 1988.
    1. Arnold LE. Contemporary Diagnosis and Management of ADHD. 3 ed Handbooks in Health Care Co; Newton, PA: 2004.
    1. Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. American Journal of Psychiatry. 2002;159:1896. - PubMed
    1. Swanson J, Kraemer H, Hinshaw S, Arnold L, Conners C, Abikoff H, et al. Clinical Relevance of the Primary Findings of the MTA: Success Rates Based on Severity of ADHD and ODD Symptoms at the End of Treatment. Journal of the American Academy of Child and Adolescent Psychiatry. 2001;40:168–179. - PubMed
    1. Kamiya J. Conscious control of brain waves. Psychology Today. 1968:57–60.

Publication types